论文部分内容阅读
格拉诺赛特(granocyte)是应用基因重组技术生产的人粒细胞集落刺激因子,其氨基酸的排列顺序和糖链的位置与天然型粒细胞集落刺激因子完全相同。1987年开始临床试用以来,证明其对肿瘤化疗所致的白细胞减少具有良好的预防和治疗作用。1995年3~10月,我们应用格拉诺赛特对24例恶性肿瘤化疗后白细胞减少的病人进行治疗,现将结果报告如下。
Granocyte is a human granulocyte colony-stimulating factor produced by gene recombination technology. Its amino acid arrangement sequence and sugar chain position are exactly the same as natural granulocyte colony-stimulating factor. Since clinical trials began in 1987, it has proved that it has a good preventive and therapeutic effect on neutropenia caused by chemotherapy of tumors. From March to October 1995, we applied Granosite to treat 24 patients with neutropenia after chemotherapy and reported the results as follows.